๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Ovarian Epithelial Cancer

ChemoINTEL Assay Algorithm Development Study: In-Vitro Cytotoxic Drug Induced Apoptosis Correlation with Patient Clinical Response to Administered Chemotherapy in Patients NCT06844136n/a1 site๐Ÿ“ Liverpool Pierian Biosciences ยท Tests: No intervention Identification of Genetic, Phenotypic, Clinical, Biological and Histological Factors Differentiating Patients With Ovarian Cancer Who Are Refractory to Platinum-based Therapy From Patients Defined as Long-term Responders to Platinum-based Therapy NCT07361471NA1 site๐Ÿ“ Clermont-Ferrand Centre Jean Perrin ยท Tests: molecular analysis Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer NCT05998135Phase 21 site๐Ÿ“ Atlanta Emory University ยท Tests: Atovaquone, Biopsy, Computed Tomography, Paracentesis Setting Up ctDNA Analysis on Archived Plasma Samples NCT07546578n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: ctDNA MIRRORS-FROZEN - Comparing Open Vs Robotic Surgery in the Management of Women with Complex Pelvic Adnexal Masses โ‰ค 8cm. NCT06638593NA1 site๐Ÿ“ Guildford Royal Surrey County Hospital NHS Foundation Trust ยท Tests: MIRRORS-FROZEN Protocol., Standard open surgery GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site๐Ÿ“ Buffalo Roswell Park Cancer Institute ยท Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion Combination Therapy for Recurrent Ovarian Cancer NCT05610735Phase 1, Phase 21 site๐Ÿ“ Louisville Sham Sunder Kakar ยท Tests: DOXIL, Withaferin A, Ashwagandha, Combination of ASWD and DOXIL MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site๐Ÿ“ Scottsdale Mayo Clinic ยท Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site๐Ÿ“ Shanghai RenJi Hospital ยท Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer NCT06019923n/a1 site๐Ÿ“ Hangzhou Women's Hospital School Of Medicine Zhejiang University ยท Tests: No intervention Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer NCT07821879n/a1 site๐Ÿ“ Toulouse Institut Claudius Regaud Pharmacokinetic Study of Tranexamic Acid NCT06728670NA1 site๐Ÿ“ Hangzhou Zhejiang Cancer Hospital ยท Tests: Tranexamic acid Intravenous Infusion, TXA intramuscular injection 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: 68Ga-SorB PET/CT A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients NCT06522828Phase 21 site๐Ÿ“ Chongqing Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. ยท Tests: SSGJ-707, carboplatin, paclitaxel CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With Advanced Chemorefractory Solid Tumors NCT05733000Phase 21 site๐Ÿ“ Chicago Northwestern University ยท Tests: Biospecimen Collection, Computed Tomography, Devimistat, Fluorouracil, Gemcitabine Hydrochloride Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites๐Ÿ“ Scottsdale๐Ÿ“ La Jolla๐Ÿ“ Stanford BioEclipse Therapeutics ยท Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries NCT07539844n/a12 sites๐Ÿ“ Buenos Aires๐Ÿ“ Buenos Aires๐Ÿ“ Ciudad Autonoma de Buenos Aire AbbVie Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors NCT07360314Phase 19 sites๐Ÿ“ New Haven๐Ÿ“ Huntersville๐Ÿ“ Galveston EMD Serono Research & Development Institute, Inc. ยท Tests: M7437, M7437 Development of a Cinical and Biological Database in Ovarian, Fallopian Tube and Peritoneal Cancers NCT03976999NA1 site๐Ÿ“ Montpellier Institut du Cancer de Montpellier - Val d'Aurelle ยท Tests: Biological collection Efficacy and Safety of Distamab Vedotin Combined With Carboplatin for Advanced Ovarian Cancer in the First Line Treatment NCT07285941Phase 21 site๐Ÿ“ Zhejiang Zhejiang Cancer Hospital ยท Tests: RC48 + Carboplatin A Three-arm Randomized Phase II Study of Dostarlimab Alone or With Bevacizumab Versus Nonplatinum Chemotherapy in Recurrent Gynecological Clear Cell Carcinoma: DOVE (APGOT-OV7/ ENGOT-ov80 Study) NCT06023862Phase 227 sites๐Ÿ“ Clayton๐Ÿ“ Waratah๐Ÿ“ Melbourne Yonsei University ยท Tests: Dostarlimab, Bevacizumab, Doxorubicin, Gemcitabine, Paclitaxel Comprehensive Outcomes for After Cancer Health NCT05349227NA7 sites๐Ÿ“ Gainesville๐Ÿ“ Boston๐Ÿ“ Omaha Pack Health ยท Tests: Digital Health Coaching Program, Fitbit A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors NCT05932862Phase 116 sites๐Ÿ“ Fountain Valley๐Ÿ“ Jacksonville๐Ÿ“ Orlando Exelixis ยท Tests: XL309, Olaparib Study of AVZO-021 in Patients With Advanced Solid Tumors NCT05867251Phase 1, Phase 213 sites๐Ÿ“ New Haven๐Ÿ“ Sarasota๐Ÿ“ Tampa Avenzo Therapeutics, Inc. ยท Tests: AVZO-021, Palbociclib, Fulvestrant, Letrozole, Ribociclib A Study of Isoquercetin in People With Ovarian Cancer NCT07303894Phase 28 sites๐Ÿ“ Boston๐Ÿ“ Basking Ridge๐Ÿ“ Middletown Memorial Sloan Kettering Cancer Center ยท Tests: Isoquercetin, Placebo Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer NCT05945407NA1 site๐Ÿ“ Beijing Peking University People's Hospital ยท Tests: Indication-extended Fertility-sparing Therapy Clinical Utility of ctDNA in Detecting Resistance Mechanisms and Delivering Precision Medicine to Cancer Patients NCT07673861NA1 site๐Ÿ“ London Royal Marsden NHS Foundation Trust ยท Tests: Marsden360 ctDNA test and GTAB review An Exploratory Study on the Use of Ipalotinib (Tislelizumab) Combined With Sunitinib and Olaparib for Neoadjuvant Therapy in HRD-positive Advanced Ovarian Cancer NCT07667751Phase 21 site๐Ÿ“ Hefei Bai-Rong Xia ยท Tests: Sunitinibใ€Olaparibใ€Tolilizumab A Cohort Study of Hereditary Ovarian Cancer Risk Prediction Models and Pathogenesis Exploration NCT06564428n/a1 site๐Ÿ“ Beijing Peking University Third Hospital ยท Tests: Suspective gene mutations and family history A Study to Explore Personalized Treatment for Patients With Recurrent Gynecological Malignancies Based on MTB NCT06781151n/a2 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen Sun Yat-sen University
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy